Table 1. Comparison of the Data in the Obese and Control Groupsa.
| Control Group 37 | Obese Group 107 | P | Power | |
|---|---|---|---|---|
| Age (year) | 10.41 ± 3.15 | 11.25 ± 3.38 | 0.184 | |
| Gender | ||||
| Female | 16 (43.24%) | 43 (40.19%) | 0.745 | |
| Male | 21 (56.76%) | 64 (59: 37%) | ||
| Cholesterol (mg/dL) | 164.08 ± 30.52 | 163.48 ± 25.63 | 0.908 | |
| LDL (mg/dL) | 87.76 ± 29.72 | 92.77 ± 26.24 | 0.337 | |
| HDL (mg/dL) | 59.73 ± 13.43 | 52.15 ± 16.23 | 0.012 | %99 |
| Triglycerides (mg/dL) | 82,81 ± 36,51 | 112,47 ± 51,74 | 0.002 | %99 |
| Fasting glucose (mU/mL) | 90.43 ± 8.34 | 90.4 ± 8.49 | 0.984 | |
| Fasting insulin (mU/mL) | 10.12 ± 9.54 | 21.81 ± 16.65 | 0.0001 | %99 |
| HOMA-IR | 2.29 ± 2.36 | 4.94 ± 4.2 | 0.0001 | %99 |
| ALT (U/L) | 14.92 ± 4.77 | 25.93 ± 14.67 | 0.0001 | %99 |
| OPG (pg/mL) | ||||
| Mean ± SD | 70.78 ± 33.41 | 55.20 ± 24.55 | ||
| Median (IQR) | 64.57 (51.63 - 74.50) | 48.81 (40.91 - 66.26) | 0.0001 | %99 |
Abbreviations: OPG, Osteoprotegerin; LDL, Low density lipoprotein; HDL, High density lipoprotein; HOMA-IR, Homeostasis model assessment-insulin resistance; ALT, Alanine aminotransferase.
aData are given as mean ± SD or n (%), data are given as mean ± SD and median for Osteoprotegerin.